Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Active Biotech AB ( (SE:ACTI) ).
Active Biotech AB has announced its upcoming Annual General Meeting scheduled for May 28, 2025, where shareholders will discuss various resolutions including the re-election of board members and the proposal to carry forward the company’s accumulated loss without paying dividends. The meeting will also address the re-election of Öhrlings PricewaterhouseCoopers AB as the auditor, indicating a stable continuity in the company’s governance and financial oversight.
More about Active Biotech AB
Active Biotech AB is a biotechnology company based in Lund, Sweden, focusing on the development of pharmaceuticals for the treatment of autoimmune diseases and cancer. The company is involved in research and development activities aimed at creating innovative therapies to address unmet medical needs.
YTD Price Performance: -21.43%
Average Trading Volume: 26,358
Technical Sentiment Signal: Strong Buy
Current Market Cap: €9.72M
Learn more about ACTI stock on TipRanks’ Stock Analysis page.